Clinical trial
A Randomized Multicenter Phase III Trial Evaluating the Interest of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST)
NCT02260505 is registered in ClinicalTrials.gov with Centre Leon Berard as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Multicenter Phase III Trial Evaluating the Interest of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST)
- Lead sponsor
- Centre Leon Berard
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 24, 2014
- Completion date
- December 31, 2023
- Enrollment
- 136 (actual)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.
gastrointestinal stromal tumors, high risk of recurrence, kit gene mutation, non-metastatic, resected gastrointestinal stromal tumors